177 related articles for article (PubMed ID: 20440523)
1. Use of valproate in women of childbearing potential: pre- and post-NICE bipolar guidelines.
Vasudev K; Mead A
Arch Womens Ment Health; 2010 Aug; 13(4):371-2. PubMed ID: 20440523
[No Abstract] [Full Text] [Related]
2. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present.
García-Portilla MP; Bobes J
Rev Psiquiatr Salud Ment; 2017; 10(3):129-133. PubMed ID: 28688547
[No Abstract] [Full Text] [Related]
3. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
[TBL] [Abstract][Full Text] [Related]
4. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
Goldspink R; Pumipi T; Dey S; Menkes DB
Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
[TBL] [Abstract][Full Text] [Related]
5. Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder.
Dusetzina SB; Gaynes BN; Weinberger M; Farley JF; Sleath B; Hansen RA
Psychiatr Serv; 2011 Dec; 62(12):1443-9. PubMed ID: 22193791
[TBL] [Abstract][Full Text] [Related]
6. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
Samalin L; Llorca PM
Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
[TBL] [Abstract][Full Text] [Related]
7. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
[TBL] [Abstract][Full Text] [Related]
8. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
[TBL] [Abstract][Full Text] [Related]
9. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
Young L; Coffey BJ
J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
[No Abstract] [Full Text] [Related]
10. NICE recommendations for valproate treatment are unhelpful.
Curtis D; Kerr M
Br J Psychiatry; 2005 May; 186():447. PubMed ID: 15863754
[No Abstract] [Full Text] [Related]
11. Valproate-related hyperammonemic encephalopathy: report of 1 case.
Selvi Y; Annagur BB; Sayin AA; Akbaba N
J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
[No Abstract] [Full Text] [Related]
12. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a "recovered" status in the systematic treatment enhancement program for bipolar disorder.
Al Jurdi RK; Marangell LB; Petersen NJ; Martinez M; Gyulai L; Sajatovic M
Am J Geriatr Psychiatry; 2008 Nov; 16(11):922-33. PubMed ID: 18978253
[TBL] [Abstract][Full Text] [Related]
13. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
Perera C; Patterson S; Bruxner G
Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
[TBL] [Abstract][Full Text] [Related]
14. Criteria for use of valproate in adult psychiatric inpatients and outpatients.
Puzantian T
Am J Health Syst Pharm; 1996 May; 53(10):1187-8. PubMed ID: 8734684
[No Abstract] [Full Text] [Related]
15. The valproate serum level in maintenance therapy for bipolar disorder in Japan.
Machino A; Jitsuiki H; Okamoto Y; Izumitani S; Kimura Y; Suzuki K; Tanaka T; Inoue T; Koyama T; Wada K; Masaoka Y; Sasaki T; Yoshimura R; Nakamura J; Sumitan S; Ohmori T; Yamawaki S
Hiroshima J Med Sci; 2013 Mar; 62(1):7-12. PubMed ID: 23600328
[TBL] [Abstract][Full Text] [Related]
16. Hormonal effects of valproic acid?
Garland EJ; Behr R
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1424-5. PubMed ID: 8936907
[No Abstract] [Full Text] [Related]
17. [Inadequate vasopressin secretion and valproate].
Franco Hidalgo S; Prieto de Paula JM; Salado Valdivieso I
Endocrinol Nutr; 2009 May; 56(5):277. PubMed ID: 19627751
[No Abstract] [Full Text] [Related]
18. Valproate prescription prevalence among women of childbearing age.
Wisner KL; Leckman-Westin E; Finnerty M; Essock SM
Psychiatr Serv; 2011 Feb; 62(2):218-20. PubMed ID: 21285103
[TBL] [Abstract][Full Text] [Related]
19. Pedal edema associated with addition of low-dose quetiapine to valproate treatment in bipolar disorder.
Chen CY; Yeh YW; Kuo SC; Shiah IS; Liu PY; Chen CL
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1551-2. PubMed ID: 19665043
[No Abstract] [Full Text] [Related]
20. [Recommendations for the treatment of mixed episodes in current guidelines].
Azorin JM; Belzeaux R; Cermolacce M; Kaladjian A; Corréard N; Dassa D; Dubois M; Maurel M; Micoulaud Franchi JA; Pringuey D; Fakra E
Encephale; 2013 Dec; 39 Suppl 3():S185-7. PubMed ID: 24359859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
